The Mental Health Research Institute is primarily involved in research. However, we also provide:
Psychotropic Drug Advice
Access independent information on medicines used to treat psychiatric illnesses from a dedicated pharmacist through the Institute’s Psychotropic Drug Advisory Service.
The Collection’s mission is to promote widely a greater understanding of people who experience mental illness and/or psychological trauma, and to foster an appreciation of their creativity through the preservation and ethical presentation of their original works.
Links to a range of service and support groups, information sources and other research groups to whom we are connected.
National Dementia Diagnostics Laboratory
Cerebrospinal Fluid Alzheimer Disease Screen
The Cerebrospinal Fluid Alzheimer Disease Screen is an ante-mortem diagnostic test that detects alterations in the levels of biomarker proteins, specifically amyloid ABeta, total-tau and phospho-tau, which are believed to be directly related to the pathophysiology of Alzheimer Disease (AD). Based on international experience, these CSF biomarkers offer approximately 80-90% sensitivity and specificity for clinically overt AD and valuable prognostic information in persons with amnestic Mild Cognitive Impairment.